Modular Medical director Morgan C. Frank gets options

Both awards were fully vested and exercisable on the September 30, 2026 grant date.

Rhea-AI Filing Summary

Modular Medical, Inc. director and 10% owner Morgan C. Frank received two grants of options to purchase common stock on September 30, 2026: 62 options and 250 options, each with an exercise price of $1.95. The options were granted under the company's Outside Director Compensation Plan.

Insider Trade Summary

Grant/Award: 312 shares

Grant/Award 2 txns

Insider FRANK MORGAN C.

Role Director, 10% Owner

Type	Security	Shares	Price	Value
Grant/Award	Option to purchase common stock F1, F2	62	--	--
Grant/Award	Option to purchase common stock F1, F2	250	--	--

Holdings After Transaction: Option to purchase common stock — 312 contracts (Direct)

Footnotes (2)

1. F1. The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.
2. F2. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

Key Figures

Options granted: 62 options to purchase common stock Options granted: 250 options to purchase common stock Exercise price: $1.95

3 metrics

Options granted 62 options to purchase common stock September 30, 2026 grant

Options granted 250 options to purchase common stock September 30, 2026 grant

Exercise price $1.95 For each option grant

Key Terms

Outside Director Compensation Plan, fully vested and exercisable, class of derivative security

3 terms

Outside Director Compensation Plan financial

"granted ... in accordance with the Issuer's Outside Director Compensation Plan"

fully vested and exercisable financial

"fully vested and exercisable on the grant date"

class of derivative security technical

"total beneficial ownership of the "class" of derivative security"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options did MODD director Morgan C. Frank receive?

Morgan C. Frank received grants of 62 options and 250 options to purchase common stock, each with an exercise price of $1.95, on September 30, 2026.

Were Morgan C. Frank's MODD options vested when granted?

Yes. The options were fully vested and exercisable on the grant date under the Outside Director Compensation Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/01/2026 - 03:21 PM Accepted by SEC EDGAR 10/01/2026 - 03:21 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FRANK MORGAN C.

(Last) (First) (Middle)

2 CALLE CANDINA, #1701

(Street)

SAN JUAN PUERTO RICO 00907

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Modular Medical, Inc. [ MODD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to purchase common stock(1)	$1.95	09/30/2026		A		62		09/30/2026	09/30/2026	Common Stock	62	(1)	62(2)	D
Option to purchase common stock(1)	$1.95	09/30/2026		A		250		09/30/2026	09/30/2026	Common Stock	250	(1)	312(2)	D

Explanation of Responses:

1. The options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan, and the options were fully vested and exercisable on the grant date.

2. In accordance with Instruction 4 to this Form, column 9 reports only total beneficial ownership of the "class" of derivative security reported in column 1. Options that have different exercise prices or vesting terms are not considered to be of the same "class."

	Morgan C. Frank By: /s/ Morgan C. Frank	10/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)